NPS PHARMACEUTICALS INC General and Administrative Expense
NPS PHARMACEUTICALS INC reported General and Administrative Expense of $36.93 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2013-02-21
- NPS PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-12-31 was $11.16M, a 55.04% increase year-over-year.
- NPS PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-09-30 was $8.33M, a 29.88% increase year-over-year.
- NPS PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-06-30 was $9.67M, a 74.58% increase year-over-year.
- NPS PHARMACEUTICALS INC general and administrative expense for the quarter ending 2012-03-31 was $7.77M, a 53.07% increase year-over-year.
- NPS PHARMACEUTICALS INC general and administrative expense for fiscal 2012 was $36.93M, a 52.44% increase from fiscal 2011.
- NPS PHARMACEUTICALS INC general and administrative expense for fiscal 2011 was $24.23M, a 27.83% increase from fiscal 2010.
- NPS PHARMACEUTICALS INC general and administrative expense for fiscal 2010 was $18.95M, a 5.72% decline from fiscal 2009.
- NPS PHARMACEUTICALS INC general and administrative expense for fiscal 2009 was $20.10M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $19.49M derived: sum of 2 quarters · filed 2013-02-21 | $29.16M derived: sum of 3 quarters · filed 2013-02-21 | $36.93M 10-K · filed 2013-02-21 |
| 2012-09-30 | $8.33M 10-Q · filed 2012-11-09 | $18.00M derived: sum of 2 quarters · filed 2012-11-09 | $25.77M 10-Q · filed 2012-11-09 | $32.97M derived: sum of 4 quarters · filed 2013-02-21 |
| 2012-06-30 | $9.67M 10-Q · filed 2012-08-01 | $17.44M 10-Q · filed 2012-08-01 | $24.64M derived: sum of 3 quarters · filed 2013-02-21 | $31.05M derived: sum of 4 quarters · filed 2013-02-21 |
| 2012-03-31 | $7.77M 10-Q · filed 2012-05-03 | $14.97M derived: sum of 2 quarters · filed 2013-02-21 | $21.38M derived: sum of 3 quarters · filed 2013-02-21 | $26.92M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $13.61M derived: sum of 2 quarters · filed 2013-02-21 | $19.15M derived: sum of 3 quarters · filed 2013-02-21 | $24.23M 10-K · filed 2013-02-21 |
| 2011-09-30 | $6.41M 10-Q · filed 2012-11-09 | $11.95M derived: sum of 2 quarters · filed 2012-11-09 | $17.03M 10-Q · filed 2012-11-09 | $22.08M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $5.54M 10-Q · filed 2012-08-01 | $10.62M 10-Q · filed 2012-08-01 | $15.67M derived: sum of 3 quarters · filed 2013-02-21 | $21.08M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $5.08M 10-Q · filed 2012-05-03 | $10.13M derived: sum of 2 quarters · filed 2013-02-21 | $15.54M derived: sum of 3 quarters · filed 2013-02-21 | $19.73M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $10.46M derived: sum of 2 quarters · filed 2013-02-21 | $14.65M derived: sum of 3 quarters · filed 2013-02-21 | $18.95M 10-K · filed 2013-02-21 |
| 2010-09-30 | $5.41M 10-Q · filed 2011-11-03 | $9.60M derived: sum of 2 quarters · filed 2011-11-03 | $13.90M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $4.19M 10-Q · filed 2011-08-02 | $8.49M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $20.10M 10-K · filed 2012-02-15 |